Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL)

 KV320_HUMAN             Reviewed;         116 AA.
P01619; A0A0B4J1Z6; P01620; P01621; P01622; P01623; P04206; P06311;
P18135; P18136;
21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
02-NOV-2016, sequence version 2.
25-OCT-2017, entry version 98.
RecName: Full=Immunoglobulin kappa variable 3-20 {ECO:0000303|PubMed:11549845, ECO:0000303|Ref.10};
AltName: Full=Ig kappa chain V-III region B6 {ECO:0000305|PubMed:11946339};
AltName: Full=Ig kappa chain V-III region GOL {ECO:0000305|PubMed:3086710};
AltName: Full=Ig kappa chain V-III region HAH {ECO:0000305|PubMed:3127527};
AltName: Full=Ig kappa chain V-III region HIC {ECO:0000305|PubMed:3127527};
AltName: Full=Ig kappa chain V-III region IARC/BL41 {ECO:0000305|PubMed:2997711};
AltName: Full=Ig kappa chain V-III region NG9 {ECO:0000305|PubMed:6419127};
AltName: Full=Ig kappa chain V-III region SIE {ECO:0000305|PubMed:6794615};
AltName: Full=Ig kappa chain V-III region Ti {ECO:0000305|PubMed:5027703};
AltName: Full=Ig kappa chain V-III region WOL {ECO:0000305|PubMed:6794615};
Flags: Precursor;
Name=IGKV3-20 {ECO:0000303|PubMed:11549845, ECO:0000303|Ref.10};
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=2997711; DOI=10.1093/nar/13.18.6499;
Klobeck H.G., Meindl A., Combriato G., Solomon A., Zachau H.G.;
"Human immunoglobulin kappa light chain genes of subgroups II and
III.";
Nucleic Acids Res. 13:6499-6513(1985).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=3127527; DOI=10.1084/jem.167.3.840;
Kipps T.J., Tomhave E., Chen P.P., Carson D.A.;
"Autoantibody-associated kappa light chain variable region gene
expressed in chronic lymphocytic leukemia with little or no somatic
mutation. Implications for etiology and immunotherapy.";
J. Exp. Med. 167:840-852(1988).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (IMGT ALLELE
IGKV3-20*01).
PubMed=15815621; DOI=10.1038/nature03466;
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2
and 4.";
Nature 434:724-731(2005).
[4]
NUCLEOTIDE SEQUENCE [MRNA] OF 17-116.
PubMed=6419127; DOI=10.1038/307077a0;
Bentley D.L.;
"Most kappa immunoglobulin mRNA in human lymphocytes is homologous to
a small family of germ-line V genes.";
Nature 307:77-80(1984).
[5]
PROTEIN SEQUENCE OF 21-116.
PubMed=11946339; DOI=10.1016/0014-5793(69)80048-7;
Milstein C.;
"The basic sequences of immunoglobulin kappa chains: sequence studies
of Bence Jones proteins Rad, Fr4 and B6.";
FEBS Lett. 2:301-304(1969).
[6]
PROTEIN SEQUENCE OF 21-116.
PubMed=5027703;
Suter L., Barnikol H.U., Watanabe S., Hilschmann N.;
"Rule of antibody structure. The primary structure of a monoclonal
immunoglobulin L-chain of kappa-type, subgroup 3 (Bence-Jones protein
Ti). IV. The complete amino acid sequence and its significance for the
mechanism of antibody production.";
Hoppe-Seyler's Z. Physiol. Chem. 353:189-208(1972).
[7]
PROTEIN SEQUENCE OF 21-116.
PubMed=6794615; DOI=10.1021/bi00523a026;
Andrews D.W., Capra J.D.;
"Amino acid sequence of the variable regions of light chains from two
idiotypically cross-reactive human IgM anti-gamma-globulins of the Wa
group.";
Biochemistry 20:5816-5822(1981).
[8]
PROTEIN SEQUENCE OF 21-116.
PubMed=3086710; DOI=10.1016/0161-5890(86)90049-0;
Newkirk M., Chen P.P., Carson D.A., Posnett D., Capra J.D.;
"Amino acid sequence of a light chain variable region of a human
rheumatoid factor of the Wa idiotypic group, in part predicted by its
reactivity with antipeptide antibodies.";
Mol. Immunol. 23:239-244(1986).
[9]
NOMEMCLATURE.
PubMed=11549845;
Lefranc M.P.;
"Nomenclature of the human immunoglobulin kappa (IGK) genes.";
Exp. Clin. Immunogenet. 18:161-174(2001).
[10]
NOMENCLATURE.
Lefranc M.P., Lefranc G.;
"The Immunoglobulin FactsBook.";
(In) Lefranc M.P., Lefranc G. (eds.);
The Immunoglobulin FactsBook., pp.1-458, Academic Press, London.
(2001).
[11]
REVIEW ON SOMATIC HYPERMUTATION.
PubMed=17576170; DOI=10.1146/annurev.genet.41.110306.130340;
Teng G., Papavasiliou F.N.;
"Immunoglobulin somatic hypermutation.";
Annu. Rev. Genet. 41:107-120(2007).
[12]
REVIEW ON IMMUNOGLOBULINS.
PubMed=20176268; DOI=10.1016/j.jaci.2009.09.046;
Schroeder H.W. Jr., Cavacini L.;
"Structure and function of immunoglobulins.";
J. Allergy Clin. Immunol. 125:S41-S52(2010).
[13]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21269460; DOI=10.1186/1752-0509-5-17;
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
"Initial characterization of the human central proteome.";
BMC Syst. Biol. 5:17-17(2011).
[14]
REVIEW ON FUNCTION.
PubMed=22158414; DOI=10.1038/nri3128;
McHeyzer-Williams M., Okitsu S., Wang N., McHeyzer-Williams L.;
"Molecular programming of B cell memory.";
Nat. Rev. Immunol. 12:24-34(2012).
[15]
NOMENCLATURE.
PubMed=24600447; DOI=10.3389/fimmu.2014.00022;
Lefranc M.P.;
"Immunoglobulin and T Cell Receptor Genes: IMGT((R)) and the Birth and
Rise of Immunoinformatics.";
Front. Immunol. 5:22-22(2014).
-!- FUNCTION: V region of the variable domain of immunoglobulin light
chains that participates in the antigen recognition
(PubMed:24600447). Immunoglobulins, also known as antibodies, are
membrane-bound or secreted glycoproteins produced by B
lymphocytes. In the recognition phase of humoral immunity, the
membrane-bound immunoglobulins serve as receptors which, upon
binding of a specific antigen, trigger the clonal expansion and
differentiation of B lymphocytes into immunoglobulins-secreting
plasma cells. Secreted immunoglobulins mediate the effector phase
of humoral immunity, which results in the elimination of bound
antigens (PubMed:20176268, PubMed:22158414). The antigen binding
site is formed by the variable domain of one heavy chain, together
with that of its associated light chain. Thus, each immunoglobulin
has two antigen binding sites with remarkable affinity for a
particular antigen. The variable domains are assembled by a
process called V-(D)-J rearrangement and can then be subjected to
somatic hypermutations which, after exposure to antigen and
selection, allow affinity maturation for a particular antigen
(PubMed:20176268, PubMed:17576170). {ECO:0000303|PubMed:17576170,
ECO:0000303|PubMed:20176268, ECO:0000303|PubMed:22158414,
ECO:0000303|PubMed:24600447}.
-!- SUBUNIT: Immunoglobulins are composed of two identical heavy
chains and two identical light chains; disulfide-linked.
{ECO:0000303|PubMed:20176268}.
-!- SUBCELLULAR LOCATION: Secreted {ECO:0000303|PubMed:20176268,
ECO:0000303|PubMed:22158414}. Cell membrane
{ECO:0000303|PubMed:20176268, ECO:0000303|PubMed:22158414}.
-!- POLYMORPHISM: There are several alleles. The sequence shown is
that of IMGT allele IGKV3-20*01.
-!- CAUTION: For an example of a full-length immunoglobulin kappa
light chain see AC P0DOX7. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=CAA77316.1; Type=Miscellaneous discrepancy; Note=Chimeric DNA. A chimeric DNA corresponding to regions V and J of immunoglobulin kappa light chain.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; Z00021; CAA77316.1; ALT_SEQ; Genomic_DNA.
EMBL; AC245015; -; NOT_ANNOTATED_CDS; Genomic_DNA.
PIR; A01891; K3HUB6.
PIR; A01892; K3HUSI.
PIR; A01893; K3HUGO.
PIR; A01894; K3HUNG.
PIR; A01895; K3HUTI.
PIR; A01896; K3HUWL.
PIR; A01899; K3HU41.
PIR; C27594; C27594.
PIR; E30607; E30607.
PIR; PL0021; K3HUHI.
PIR; PL0022; K3HUHA.
UniGene; Hs.449609; -.
UniGene; Hs.719895; -.
PDB; 1DH5; Model; -; L=21-116.
PDB; 4LRN; X-ray; 1.89 A; L=21-116.
PDB; 4M62; X-ray; 1.80 A; L/M=21-116.
PDB; 4M8Q; X-ray; 2.89 A; B/L=21-116.
PDB; 4OB5; X-ray; 1.70 A; L=21-116.
PDB; 4ODX; X-ray; 3.10 A; B/L=21-116.
PDBsum; 1DH5; -.
PDBsum; 4LRN; -.
PDBsum; 4M62; -.
PDBsum; 4M8Q; -.
PDBsum; 4OB5; -.
PDBsum; 4ODX; -.
ProteinModelPortal; P01619; -.
SMR; P01619; -.
IntAct; P01619; 2.
MINT; MINT-202307; -.
IMGT_GENE-DB; IGKV3-20; -.
DMDM; 125795; -.
DMDM; 125797; -.
DMDM; 125799; -.
DMDM; 125801; -.
DMDM; 125803; -.
DMDM; 125807; -.
DMDM; 125817; -.
PeptideAtlas; P01619; -.
PRIDE; P01619; -.
TopDownProteomics; P18135; -.
Ensembl; ENST00000492167; ENSP00000418649; ENSG00000239951.
Ensembl; ENST00000632822; ENSP00000487628; ENSG00000282402.
DisGeNET; 28912; -.
EuPathDB; HostDB:ENSG00000239951.1; -.
GeneCards; IGKV3-20; -.
H-InvDB; HIX0029811; -.
HGNC; HGNC:5817; IGKV3-20.
neXtProt; NX_P01619; -.
OpenTargets; ENSG00000239951; -.
GeneTree; ENSGT00780000121852; -.
HOVERGEN; HBG018013; -.
OMA; GNSWIAW; -.
PhylomeDB; P01619; -.
Reactome; R-HSA-166663; Initial triggering of complement.
Reactome; R-HSA-173623; Classical antibody-mediated complement activation.
Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
Reactome; R-HSA-2029481; FCGR activation.
Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
Reactome; R-HSA-2029485; Role of phospholipids in phagocytosis.
Reactome; R-HSA-2168880; Scavenging of heme from plasma.
Reactome; R-HSA-2454202; Fc epsilon receptor (FCERI) signaling.
Reactome; R-HSA-2730905; Role of LAT2/NTAL/LAB on calcium mobilization.
Reactome; R-HSA-2871796; FCERI mediated MAPK activation.
Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
Reactome; R-HSA-5690714; CD22 mediated BCR regulation.
Reactome; R-HSA-977606; Regulation of Complement cascade.
Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
PRO; PR:P01619; -.
Proteomes; UP000005640; Chromosome 2.
Bgee; ENSG00000239951; -.
GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
GO; GO:0005576; C:extracellular region; TAS:Reactome.
GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
GO; GO:0071748; C:monomeric IgA immunoglobulin complex; IDA:UniProtKB.
GO; GO:0071756; C:pentameric IgM immunoglobulin complex; IDA:UniProtKB.
GO; GO:0005886; C:plasma membrane; TAS:Reactome.
GO; GO:0071751; C:secretory IgA immunoglobulin complex; IDA:UniProtKB.
GO; GO:0003823; F:antigen binding; NAS:UniProtKB.
GO; GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome.
GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
GO; GO:0006956; P:complement activation; TAS:Reactome.
GO; GO:0006958; P:complement activation, classical pathway; TAS:Reactome.
GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
GO; GO:0003094; P:glomerular filtration; IMP:UniProtKB.
GO; GO:0006955; P:immune response; NAS:UniProtKB.
GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
GO; GO:0030449; P:regulation of complement activation; TAS:Reactome.
GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
InterPro; IPR007110; Ig-like_dom.
InterPro; IPR036179; Ig-like_dom_sf.
InterPro; IPR003599; Ig_sub.
InterPro; IPR013106; Ig_V-set.
Pfam; PF07686; V-set; 1.
SMART; SM00409; IG; 1.
SMART; SM00406; IGv; 1.
SUPFAM; SSF48726; SSF48726; 1.
PROSITE; PS50835; IG_LIKE; 1.
1: Evidence at protein level;
3D-structure; Adaptive immunity; Cell membrane; Complete proteome;
Direct protein sequencing; Disulfide bond; Immunity;
Immunoglobulin domain; Immunoglobulin V region; Membrane;
Polymorphism; Reference proteome; Secreted; Signal.
SIGNAL 1 20 {ECO:0000269|PubMed:11946339,
ECO:0000269|PubMed:3086710,
ECO:0000269|PubMed:5027703,
ECO:0000269|PubMed:6794615}.
CHAIN 21 116 Immunoglobulin kappa variable 3-20.
{ECO:0000269|PubMed:11946339,
ECO:0000269|PubMed:3086710,
ECO:0000269|PubMed:5027703,
ECO:0000269|PubMed:6794615}.
/FTId=PRO_0000059762.
DOMAIN 21 >116 Ig-like. {ECO:0000255|PROSITE-
ProRule:PRU00114}.
REGION 21 43 Framework-1.
{ECO:0000303|PubMed:2997711}.
REGION 44 55 Complementarity-determining-1.
{ECO:0000303|PubMed:2997711}.
REGION 56 70 Framework-2.
{ECO:0000303|PubMed:2997711}.
REGION 71 77 Complementarity-determining-2.
{ECO:0000303|PubMed:2997711}.
REGION 78 109 Framework-3.
{ECO:0000303|PubMed:2997711}.
REGION 110 >116 Complementarity-determining-3.
{ECO:0000303|PubMed:2997711}.
DISULFID 43 109 {ECO:0000255|PROSITE-ProRule:PRU00114}.
CONFLICT 17 19 DTT -> VPS (in Ref. 4). {ECO:0000305}.
CONFLICT 38 38 R -> S (in Ref. 1; CAA77316).
{ECO:0000305}.
CONFLICT 40 40 T -> A (in Ref. 5; AA sequence).
{ECO:0000305}.
CONFLICT 46 52 SQSVSSS -> ALLSSRG (in Ref. 8; AA
sequence). {ECO:0000305}.
CONFLICT 49 52 VSSS -> LSGN (in Ref. 5; AA sequence).
{ECO:0000305}.
CONFLICT 51 51 S -> N (in Ref. 7; AA sequence and 6; AA
sequence). {ECO:0000305}.
CONFLICT 52 53 SY -> N (in Ref. 1; CAA77316).
{ECO:0000305}.
CONFLICT 52 52 S -> G (in Ref. 7; AA sequence).
{ECO:0000305}.
CONFLICT 53 53 Y -> F (in Ref. 6; AA sequence).
{ECO:0000305}.
CONFLICT 55 55 A -> G (in Ref. 7; AA sequence).
{ECO:0000305}.
CONFLICT 61 61 P -> R (in Ref. 1; CAA77316).
{ECO:0000305}.
CONFLICT 64 64 A -> S (in Ref. 1; CAA77316).
{ECO:0000305}.
CONFLICT 69 69 I -> M (in Ref. 5; AA sequence and 8; AA
sequence). {ECO:0000305}.
CONFLICT 70 71 YG -> RD (in Ref. 1; CAA77316).
{ECO:0000305}.
CONFLICT 71 71 G -> V (in Ref. 6; AA sequence).
{ECO:0000305}.
CONFLICT 72 72 A -> V (in Ref. 5; AA sequence).
{ECO:0000305}.
CONFLICT 73 73 S -> T (in Ref. 4). {ECO:0000305}.
CONFLICT 77 77 T -> N (in Ref. 1; CAA77316).
{ECO:0000305}.
CONFLICT 87 87 G -> A (in Ref. 4). {ECO:0000305}.
CONFLICT 90 90 T -> A (in Ref. 5; AA sequence).
{ECO:0000305}.
CONFLICT 95 95 T -> I (in Ref. 1; CAA77316).
{ECO:0000305}.
CONFLICT 102 102 E -> D (in Ref. 7; AA sequence).
{ECO:0000305}.
CONFLICT 113 113 G -> S (in Ref. 1; CAA77316).
{ECO:0000305}.
CONFLICT 114 116 SSP -> NSQ (in Ref. 4). {ECO:0000305}.
CONFLICT 114 114 S -> T (in Ref. 2 and 1; CAA77316).
{ECO:0000305}.
CONFLICT 115 116 SP -> LG (in Ref. 7; AA sequence).
{ECO:0000305}.
NON_TER 116 116
STRAND 24 27 {ECO:0000244|PDB:4OB5}.
STRAND 29 33 {ECO:0000244|PDB:4OB5}.
STRAND 39 47 {ECO:0000244|PDB:4OB5}.
HELIX 50 52 {ECO:0000244|PDB:4OB5}.
STRAND 54 59 {ECO:0000244|PDB:4OB5}.
STRAND 66 70 {ECO:0000244|PDB:4OB5}.
TURN 71 73 {ECO:0000244|PDB:4OB5}.
STRAND 83 88 {ECO:0000244|PDB:4OB5}.
STRAND 91 98 {ECO:0000244|PDB:4OB5}.
HELIX 101 103 {ECO:0000244|PDB:4OB5}.
STRAND 105 111 {ECO:0000244|PDB:4OB5}.
STRAND 113 116 {ECO:0000244|PDB:4OB5}.
SEQUENCE 116 AA; 12557 MW; FAC198A8B24553DD CRC64;
METPAQLLFL LLLWLPDTTG EIVLTQSPGT LSLSPGERAT LSCRASQSVS SSYLAWYQQK
PGQAPRLLIY GASSRATGIP DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYGSSP


Related products :

Catalog number Product name Quantity
RM53_MOUSE Human ELISA Kit FOR Ig kappa chain C region 96T
E0525r Human ELISA Kit FOR Ig kappa chain C region 96T
KV5A9_MOUSE Mouse ELISA Kit FOR Ig kappa chain V-V region L7 96T
E15049h Human ELISA Kit FOR Ig kappa chain V-I region HK102 96T
CSB-EL011443HU Human Ig kappa chain V-IV region(IGKV4-1) ELISA kit 96T
CSB-EL011340HU Human Ig kappa chain C region(IGKC) ELISA kit 96T
E0524b Mouse ELISA Kit FOR Ig kappa chain V-II region VKappa167 96T
PC11Y_HUMAN Mouse ELISA Kit FOR Ig kappa chain V-II region VKappa167 96T
CSB-EL011443HU Human Ig kappa chain V-IV region(IGKV4-1) ELISA kit SpeciesHuman 96T
CSB-EL011359HU Human Ig kappa chain V-I region HK102(IGKV1-5) ELISA kit 96T
CSB-EL011340HU Human Ig kappa chain C region(IGKC) ELISA kit SpeciesHuman 96T
CSB-EL011359HU Human Ig kappa chain V-I region HK102(IGKV1-5) ELISA kit SpeciesHuman 96T
KV5A9_MOUSE ELISA Kit FOR Ig kappa chain V-V region L7; organism: Mouse; gene name: Gm10881 96T
KV2A2_MOUSE ELISA Kit FOR Ig kappa chain V-II region VKappa167; organism: Mouse; gene name: Gm5153 96T
KV5A7_MOUSE ELISA Kit FOR Ig kappa chain V-V region MOPC 41; organism: Mouse; gene name: Gm5571 96T
1107NF-v1056 Monoclonal Antibodies: Mab to Kappa Light Chain; reactive species: Human; Clone: KP-53; Isotype: IgG1, k; Specificity: Kappa Light Chain 0.5/ml
1107NF-V7080 Monoclonal Antibodies: Kappa Light Chain; reactive species: Human; Clone: B479; Isotype: IgG1; Specificity: Kappa Light Chain 0.5/ml
orb82193 Human Anti-Human IgE ((kappa chain) chain) and (lambda chain) antibody IgE, kappa and lambda is a purified human immunoglobulin. 100
orb81942 Human Anti-Human (kappa chain) (L) antibody Kappa Light Chain is a purified human immunoglobulin. 1 mg
X1210P Mouse kappa chain Goat anti-mouse kappa chain-HRP Second Step Reagents 500
orb21519 Rabbit IgG Against Human Ig Kappa Light Chain Polyclonal Biotin-conjugated IgG fraction of polyclonal rabbit antiserum to human Ig kappa chain, free and bound. To identify light chain type in immunocy 10 mg
orb81859 Human Anti-Human IgE ((kappa chain) chain) antibody IgE, kappa is a purified human immunoglobulin. 1 mg
orb81882 Human Anti-Human IgE ((kappa chain) chain) antibody IgE, kappa is a purified human immunoglobulin. 1 ml
orb82306 Human Anti-Human IgE ((kappa chain) chain) antibody IgE, kappa is a purified human immunoglobulin. 100
SCH-MCA49P MOUSE ANTI RAT KAPPA LIGHT CHAIN HRP, Product Type Monoclonal Antibody, Specificity KAPPA LIGHT CHAIN , Target Species Rat, Host Mouse, Format HRP, Isotypes IgG2a, Applications E, Clone OX_12 0.5 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur